Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 235 are a BUY (95.53%), 10 are a HOLD (4.07%), 1 are a SELL (0.41%).
Analyst Jason Butler, carries an average stock price target met ratio of 36.51% that have a potential upside of 43.94% achieved within 176 days. Previously, Jason Butler worked at JMP.
Jason Butler’s has documented 464 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on PGEN, Precigen at 20-Mar-2025.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$20
$2.93 (17.16%)
$20
28 days ago
(07-Mar-2025)
16/21 (76.19%)
$2.39 (13.57%)
172
Buy
$27
$9.93 (58.17%)
$27
1 months 8 days ago
(27-Feb-2025)
7/21 (33.33%)
$7.66 (39.61%)
118
Buy
$28
$10.93 (64.03%)
$28
1 months 8 days ago
(27-Feb-2025)
0/6 (0%)
$8.66 (44.78%)
Buy
$28
$10.93 (64.03%)
$28
1 months 8 days ago
(27-Feb-2025)
25/37 (67.57%)
$8.66 (44.78%)
486
Hold
$22
$4.93 (28.88%)
$24
1 months 24 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?